Google Übersetzer
About
Neuren Pharmaceuticals Ltd (AU:NEU) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 8 2026
DAYBUE STIX now broadly available in US for Rett syndrome
Mar 3 2026
Acadia confirms plan to request CHMP re-examination
Feb 27 2026
2025 royalty income A$65m, profit after tax A$30m
Feb 27 2026
Appendix 4E and 2025 full year accounts
Feb 26 2026
Acadia reports DAYBUE net sales for 2025 and 2026 guidance
Financials
Revenue
A$64.65 M
Market Cap
A$1.52 B
P/E Ratio
52.30
EPS
0.23